GLP-1 receptor agonism extends median lifespan in mice
A September Nature Aging research highlight reported lifespan extension from GLP-1 receptor agonism in mice.
AgeBeacon editorial summary · Source publication:
Why it matters
GLP-1 medicines already have extensive human cardiometabolic evidence, so a mouse lifespan signal is especially relevant to geroscience hypotheses.
Beacon take
The lifespan finding is in mice. Human cardiovascular and metabolic benefits in indicated populations should not be presented as proof that GLP-1 therapy extends human lifespan.
Read the source
This is an AgeBeacon interpretation of research published elsewhere. Check the original paper or record for methods, results and limitations.
Nature Aging · Research highlightEducational information, not medical advice. Evidence categories describe the research cited, not a recommendation to use a treatment.
← All research briefs